Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04550494
Title Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)

ovarian cancer

prostate cancer

breast cancer

stomach cancer

pancreatic cancer



Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST